- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
$3million grant for Diabetes Research to an Indian American doctor, Nikhil Dhurandhar
![$3million grant for Diabetes Research to an Indian American doctor, Nikhil Dhurandhar $3million grant for Diabetes Research to an Indian American doctor, Nikhil Dhurandhar](https://medicaldialogues.in/wp-content/uploads/2015/07/Dhurandhar_Nikhil1.jpg)
Nikhil Dhurandhar, who is president of the Obesity Society has based his research on adenovirus 36, which causes obesity but also releases a protein that reduces the blood sugar level
An Indian-American doctor, Dr Nikhil Dhurandhar has been awarded a $3 million grant to continue his research for treatment of diabetes. Dhurandhar research is a paradoxical situation in itself; it is based on an adenovirus 36 which causes obesity in humans, yet release a protein that reduces the glucose level in the blood.
Dhurandhar first made this interesting observation years ago in rodents while researching how the virus causes obesity. A protein was isolated from the virus that is responsible for reducing blood sugar, and eventually tested on diabetic cells and animals. The result was conclusive, with the protein leading to a marked improvement in diabetes.
The next step was to focus to develop a drug that could be tested on humans and Dhurandhar currently holds a number of patents for his work on adenovirus 36.
Dhurandhar, who is president of the Obesity Society, has been studying viral obesity for years, which he started when he was a physician in India focusing on patients with obesity.
An Indian-American doctor, Dr Nikhil Dhurandhar has been awarded a $3 million grant to continue his research for treatment of diabetes. Dhurandhar research is a paradoxical situation in itself; it is based on an adenovirus 36 which causes obesity in humans, yet release a protein that reduces the glucose level in the blood.
Dhurandhar first made this interesting observation years ago in rodents while researching how the virus causes obesity. A protein was isolated from the virus that is responsible for reducing blood sugar, and eventually tested on diabetic cells and animals. The result was conclusive, with the protein leading to a marked improvement in diabetes.
The next step was to focus to develop a drug that could be tested on humans and Dhurandhar currently holds a number of patents for his work on adenovirus 36.
Dhurandhar, who is president of the Obesity Society, has been studying viral obesity for years, which he started when he was a physician in India focusing on patients with obesity.
Next Story